Clinical trial
Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in…
NCT00419172 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00419172 |
|---|---|
| Title | Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers |
| Official title | A Phase I, Single Center, Open-label, One-sequence Cross-over Study to Investigate the Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Deferasirox, Rifampicin |
| Enrollment | 22 |
| Start date | Jan 1, 2007 |
| First posted | Jan 8, 2007 |
| Last update posted | Nov 19, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: